Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David A Shapiro, MD
Intercept Pharmaceuticals - Chief Medical Officer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Karls-Franzens University
Graz, Austria
- University of Calgary
Calgary, Alberta, Canada
- University of Alberta
Edmonton, Alberta, Canada
- University of Manitoba
Winnipeg, Manitoba, Canada
- University of Toronto Western Hospital
Toronto, Ontario, Canada
- Centre de Recherche Du Chum / University of Montreal
Montreal, Quebec, Canada
- Hopital de L'Hotel Dieu
Lyon, France
- Johann Wolfgang Goethe University
Frankfurt, Germany
- University Medical Centre Hamburg-Eppendorf
Hamburg, Germany
- Medical School of Hannover
Hanover, Germany
- University of Munich
Munich, Germany
- Amc University of Amsterdam
Amsterdam, Netherlands
- Erasmus Medical Centre
Rotterdam, Netherlands
- Hospital Clinic I Provincial
Barcelona, Spain
- Queen Elizabeth Medical Center
Edgbaston, Birmingham, United Kingdom
- Royal Free Hospital
Hampstead, London, United Kingdom
- John Radcliffe Hospital
Headington, Oxford, United Kingdom
- Royal Infirmary
Edinburgh, United Kingdom
- University Upon Tyne/newcastle
Newcastle upon Tyne, United Kingdom
- U Florida Hepatology
Gainesville, Florida, United States
- University of Miami - Center for Liver Diseases
Miami, Florida, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Henry Ford Health Center Columbus
Novi, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Saint Louis University
St Louis, Missouri, United States
- Beth Israel Medical Center
New York, New York, United States
- Mt. Sinai School of Medicine
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Mcguire Dvamc
Richmond, Virginia, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2007
- Primary completion
- 31 Aug 2009
- Completion
- 31 Dec 2010
- Last update posted
- 6 Feb 2024
- Registered enrollment
- 165
- Registry id
- NCT00550862
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.